In February last year we announced a partnership with Intellectual Ventures’ Global Good fund, to develop a test to support cervical cancer screening in low- and middle-income countries (LMICs). We are jointly developing
Next week, world leaders will meet to take part in the first UN High Level Meeting on TB, in history. As QuantuMDx is the only UK company accredited to attend
QuantuMDx Group Ltd today announced two key leadership appointments. Dr Allan Brown has been appointed Chief Operating Officer and David Matthews joins as Chief Financial Officer. “These appointments represent the
To celebrate our 10th birthday this year, we’ve produced an infographic to chart our incredible journey, from a makeshift laboratory in a Sussex garage, to performance testing of our Q-POC™
We’re launching a new ‘Staff Spotlight’ feature: a Q&A with members of Team QuantuMDx to gain an insight into their role, career highlights and ambitions. This month we’ve interviewed Jennifer
The Consul General of India, Dr Aman Puri, visited Newcastle upon Tyne yesterday which included a tour of laboratories at QuantuMDx Group Limited (QuantuMDx). As a life science tools and diagnostics company, QuantuMDx
QuantuMDx Group has been awarded ISO 13485: 2016 certification – representing the highest standard of quality a medical devices company can achieve. ISO 13485 is a quality system standard designed
To coincide with World TB Day, Mark Ware, Patient Engagement and Training Manager at QuantuMDx, highlights the importance of end user engagement when devising point of care diagnostic tools for infectious
Newcastle upon Tyne, UK – 23 January 2018 Life science tools and diagnostics company QuantuMDx announced today it has closed a $12m funding round. As part of this round it
